Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen
Proteine und Peptide

Cynomolgus CD20 Full Length Protein (VLP)

Produktgrößen
20 ug
£1237,00
CD0-C52P5-20UG
100 ug
£1872,00
CD0-C52P5-100UG
500 ug
£5040,00
CD0-C52P5-500UG
Über dieses Produkt
SKU:
CD0-C52P5
Buffer:
PBS, Arginine, pH7.4
Weitere Details:
A B-lymphocyte surface antigen expressed from pre-B to mature B cells, but absent on plasma cells. It functions as a calcium channel and is a validated immunotherapy target, famously exploited by rituximab for treating B-cell malignancies and autoimmune disorders.
Immunogen:
CD20
Physischer Zustand:
Liquid
Versandbedingungen:
Dry Ice
Lagerbedingungen:
-70[o]C
Hersteller:
ACRO Biosystems
Typ:
Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins
Immobilized Cynomolgus CD20 Full Length Protein (VLP) (Cat. No. CD0-C52P5) at 5 ug/mL (100 uL/well) can bind Rituximab biosimilar with a linear range of 0.02-0.625 ug/mL (QC tested).
Immobilized Cynomolgus CD20 Full Length Protein (VLP) (Cat. No. CD0-C52P5) at 5 ug/mL (100 uL/well) can bind Ofatumumab biosimilar with a linear range of 0.005-0.156 ug/mL (QC tested).